BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30578148)

  • 1. Epidemiologic characteristics of adult candidemic patients in a secondary hospital in Kuwait: A retrospective study.
    Alobaid K; Khan Z
    J Mycol Med; 2019 Apr; 29(1):35-38. PubMed ID: 30578148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing epidemiology of candidemia in a medical center in middle Taiwan.
    Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing trends in epidemiology and antifungal susceptibility patterns of six bloodstream Candida species isolates over a 12-year period in Kuwait.
    Khan Z; Ahmad S; Al-Sweih N; Mokaddas E; Al-Banwan K; Alfouzan W; Al-Obaid I; Al-Obaid K; Asadzadeh M; Jeragh A; Joseph L; Varghese S; Vayalil S; Al-Musallam O
    PLoS One; 2019; 14(5):e0216250. PubMed ID: 31042770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.
    Doi AM; Pignatari AC; Edmond MB; Marra AR; Camargo LF; Siqueira RA; da Mota VP; Colombo AL
    PLoS One; 2016; 11(1):e0146909. PubMed ID: 26808778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
    Chander J; Singla N; Sidhu SK; Gombar S
    J Infect Dev Ctries; 2013 Sep; 7(9):670-5. PubMed ID: 24042103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients.
    Zhang W; Song X; Wu H; Zheng R
    BMC Infect Dis; 2020 Jul; 20(1):506. PubMed ID: 32660641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.
    Wu PF; Liu WL; Hsieh MH; Hii IM; Lee YL; Lin YT; Ho MW; Liu CE; Chen YH; Wang FD
    Emerg Microbes Infect; 2017 Oct; 6(10):e87. PubMed ID: 29018251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.
    Tadec L; Talarmin JP; Gastinne T; Bretonnière C; Miegeville M; Le Pape P; Morio F
    Mycoses; 2016 May; 59(5):296-303. PubMed ID: 26806101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
    Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
    Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China.
    Xiao Z; Wang Q; Zhu F; An Y
    Antimicrob Resist Infect Control; 2019; 8():89. PubMed ID: 31161036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
    Calvo B; Melo AS; Perozo-Mena A; Hernandez M; Francisco EC; Hagen F; Meis JF; Colombo AL
    J Infect; 2016 Oct; 73(4):369-74. PubMed ID: 27452195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia.
    Falces-Romero I; Romero-Gómez MP; Moreno-Ramos F; Mingorance J; García-Rodríguez J; Cendejas-Bueno E
    Med Mycol; 2021 Apr; 59(4):350-354. PubMed ID: 32634233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of risk factors and outcomes of Candida auris candidemia with non-Candida auris candidemia: A retrospective study from Pakistan.
    Sayeed MA; Farooqi J; Jabeen K; Mahmood SF
    Med Mycol; 2020 Aug; 58(6):721-729. PubMed ID: 31773169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
    Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
    Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.